NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE and ACCIDENTAL EXPOSURE TO PRODUCT

Overview

ACCIDENTAL EXPOSURE TO PRODUCT is the #6 most commonly reported adverse reaction for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, manufactured by Amneal Pharmaceuticals NY LLC. There are 17 FDA adverse event reports linking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE to ACCIDENTAL EXPOSURE TO PRODUCT. This represents approximately 2.5% of all 690 adverse event reports for this drug.

Patients taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE who experience accidental exposure to product should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ACCIDENTAL EXPOSURE TO PRODUCT is a less commonly reported adverse event for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, but still significant enough to appear in the safety profile.

Other Side Effects of NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE

In addition to accidental exposure to product, the following adverse reactions have been reported for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE:

• EAR DISCOMFORT — 35 reports
• EYE IRRITATION — 31 reports
• PAIN — 21 reports
• INCORRECT ROUTE OF DRUG ADMINISTRATION — 19 reports
• DRUG INEFFECTIVE — 18 reports
• EAR PAIN — 17 reports
• EYE PAIN — 17 reports
• OFF LABEL USE — 17 reports
• HYPOACUSIS — 16 reports
• OCULAR HYPERAEMIA — 16 reports

Other Drugs Associated with ACCIDENTAL EXPOSURE TO PRODUCT

The following drugs have also been linked to accidental exposure to product in FDA adverse event reports:

Does NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE cause ACCIDENTAL EXPOSURE TO PRODUCT?

ACCIDENTAL EXPOSURE TO PRODUCT has been reported as an adverse event in 17 FDA reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ACCIDENTAL EXPOSURE TO PRODUCT with NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE?

ACCIDENTAL EXPOSURE TO PRODUCT accounts for approximately 2.5% of all adverse event reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, making it a notable side effect.

What should I do if I experience ACCIDENTAL EXPOSURE TO PRODUCT while taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE?

If you experience accidental exposure to product while taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages